Cullinan Oncology Common
(CGEM)
|
16.6 |
$82M |
|
7.6M |
10.76 |
Iveric Bio Common
|
9.6 |
$48M |
|
1.2M |
39.34 |
Chinook Therapeutics Common
|
7.8 |
$39M |
|
1.0M |
38.42 |
Geron Corporation Common
(GERN)
|
5.9 |
$30M |
|
9.2M |
3.21 |
Reata Pharmaceuticals Common
|
4.8 |
$24M |
|
235k |
101.96 |
iTeos Therapeutics Common
(ITOS)
|
4.7 |
$23M |
|
1.7M |
13.24 |
Intellia Therapeutics Common
(NTLA)
|
4.5 |
$22M |
|
545k |
40.78 |
Iovance Biotherapeutics Common
(IOVA)
|
4.2 |
$21M |
|
3.0M |
7.04 |
Repare Therapeutics Common
(RPTX)
|
3.5 |
$17M |
|
1.6M |
10.58 |
Relay Therapeutics Common
(RLAY)
|
3.4 |
$17M |
|
1.4M |
12.56 |
Verve Therapeutics Common
(VERV)
|
3.2 |
$16M |
|
858k |
18.75 |
Moonlake Immunotherapeutics Common
(MLTX)
|
3.0 |
$15M |
|
295k |
51.00 |
Regenxbio Common
(RGNX)
|
2.6 |
$13M |
|
657k |
19.99 |
Karuna Therapeutics Common
|
2.3 |
$12M |
|
53k |
216.85 |
Insmed Incorporated Common
(INSM)
|
2.3 |
$11M |
|
530k |
21.10 |
Xeris Biopharma Holdings Common
(XERS)
|
2.1 |
$10M |
|
4.0M |
2.62 |
Madrigal Pharmaceuticals Common
(MDGL)
|
1.8 |
$8.8M |
|
38k |
231.00 |
Crinetics Pharmaceuticals Common
(CRNX)
|
1.7 |
$8.6M |
|
479k |
18.02 |
Travere Therapeutics Common
(TVTX)
|
1.7 |
$8.5M |
|
553k |
15.36 |
Revolution Medicines Common
(RVMD)
|
1.5 |
$7.3M |
|
273k |
26.75 |
Werewolf Therapeutics Common
(HOWL)
|
1.5 |
$7.3M |
|
2.4M |
3.05 |
Kalvista Pharmaceuticals Common
(KALV)
|
1.4 |
$6.9M |
|
762k |
9.00 |
Axsome Therapeutics Common
(AXSM)
|
1.4 |
$6.7M |
|
94k |
71.86 |
Amicus Therapeutics Common
(FOLD)
|
1.3 |
$6.5M |
|
516k |
12.56 |
Avadel Pharmaceuticals Sponsored ADR
|
1.3 |
$6.3M |
|
385k |
16.48 |
Viridian Therapeutics Common
(VRDN)
|
1.2 |
$6.1M |
|
255k |
23.79 |
Edgewise Therapeutics Common
(EWTX)
|
1.1 |
$5.5M |
|
713k |
7.75 |
Adaptimmune Therapeutics Common
(ADAP)
|
0.9 |
$4.7M |
|
5.1M |
0.93 |
Olema Pharmaceuticals Common
(OLMA)
|
0.8 |
$4.2M |
|
463k |
9.03 |
Phathom Pharmaceuticals Common
(PHAT)
|
0.8 |
$4.0M |
|
282k |
14.32 |
Harpoon Therapeutics Common
|
0.5 |
$2.3M |
|
3.2M |
0.71 |
Inozyme Pharma Common
(INZY)
|
0.4 |
$1.8M |
|
327k |
5.57 |
Ventyx Biosciences Common
(VTYX)
|
0.2 |
$1.0M |
|
32k |
32.80 |
Oncorus Common
|
0.0 |
$96k |
|
2.4M |
0.04 |